Results · Apr-Jun 2026 · filed 6 Aug 2026
HealthCare Global Enterprises Q1 FY27 results
Sales grew 13% to ₹695 crore from ₹613 crore in Apr-Jun 2025.
Operating profit grew 13% to ₹122 crore, an operating margin of 17.6% (unchanged from a year ago).
Net profit grew 175% to ₹16.5 crore from ₹6 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +7%, net profit +307%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 695.1 | 613.2 | +13% |
| Operating profit (EBITDA) | 122.3 | 107.8 | +13% |
| Operating margin | 17.6% | 17.6% | 0.0 pts |
| Net profit | 16.5 | 6.0 | +175% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
HCG reported Apr–Jun 2026 revenue of ₹695 crore, up 13% from a year earlier, with adjusted EBITDA of ₹134 crore & margins expanding 120 bps to 19.4%. Management expects mid-teens revenue growth & targets 24-25% EBITDA margins over 4-5 years.
The last 7 quarters
Filings that week
- 10 Aug 2026Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- 8 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 6 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 6 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 6 Aug 2026Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- 6 Aug 2026Statement Of Variation Or Deviation Of The Proceeds Of Rights Issue For The Quarter Ended June 30, 2026.
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.